Mice carrying sh4EBP1 GL-261 tumors showed a significant extension of survival compared to mice with control (shScr) tumors (Fig. 6I), suggesting that 4EBP1 promotes glioma aggressiveness even in the presence of a functional immune system. This evidence concerns the gene EIF4EBP1 and central nervous system cancer.